IPL344
IPL344 protects cells of various types from pro-apoptotic pressures and activates the Akt signaling system. IPL344 can be used for research of amyotrophic lateral sclerosis (ALS) [1][2].
Product Specifications
CAS Number
877120-59-7
UNSPSC
12352209
Target
Akt
Type
Peptides
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ipl344.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1N(CCC1)C([C@@H](N)CC(C)C)=O)N2[C@@H](CCC2)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=C(C=C4)O)C(N5[C@@H](CCC5)C(O)=O)=O)=O)=O)=O
Molecular Formula
C41H61N7O9
Molecular Weight
795.96
References & Citations
[1]Eran Ovadia, et al. Peptide compounds and methods of treating diseases using same. Patent. WO 2021/144798 Al|[2]Meglio M. Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS[J]. Neurology Times, 2022: NA-NA.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA751530 100 µL
Homeobox protein cut-like 1 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 